nature immunology Microglia are necessary for brain development and for the maintenance of normal brain physiology. However, when brain homeostasis is perturbed, microglia react and execute immunological functions. In the context of diseases, activation of microglia can contribute to rather contrasting effects: they can promote neuronal cell death in the case of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, and can promote cell growth and invasion in the case of glioma 1,2 . In fact, microglia are attracted toward gliomas in large numbers, and microglia density in gliomas positively correlates with malignancy, invasiveness and grading of tumors. Tumor cells shut down the inflammatory properties of microglia and modulate them to exert tumor-trophic functions. Microglia release several factors, including extracellular matrix proteases and cytokines, that in turn directly or indirectly influence tumor invasiveness and growth 1,2 . As further evidence of their essential role in glioma progression, removal of microglia, in both brain organotypic slices and genetic mouse models, inhibits glioma invasiveness 3,4 . Moreover, targeting cells in the glioma microenvironment, such as tumor-associated macrophages and microglia, has been proposed as an intervention for combating glioma expansion 5, 6 .
Microglia are necessary for brain development and for the maintenance of normal brain physiology. However, when brain homeostasis is perturbed, microglia react and execute immunological functions. In the context of diseases, activation of microglia can contribute to rather contrasting effects: they can promote neuronal cell death in the case of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, and can promote cell growth and invasion in the case of glioma 1, 2 . In fact, microglia are attracted toward gliomas in large numbers, and microglia density in gliomas positively correlates with malignancy, invasiveness and grading of tumors. Tumor cells shut down the inflammatory properties of microglia and modulate them to exert tumor-trophic functions. Microglia release several factors, including extracellular matrix proteases and cytokines, that in turn directly or indirectly influence tumor invasiveness and growth 1, 2 . As further evidence of their essential role in glioma progression, removal of microglia, in both brain organotypic slices and genetic mouse models, inhibits glioma invasiveness 3, 4 . Moreover, targeting cells in the glioma microenvironment, such as tumor-associated macrophages and microglia, has been proposed as an intervention for combating glioma expansion 5, 6 .
Delineating the molecular mechanisms that provide the control of microglia activation toward a tumor-supporting phenotype in response to cues from glioma cells is of considerable interest. A published study found a caspase-dependent signaling pathway that controls microglia pro-inflammatory activation and associated neurotoxicity. It was shown that the orderly activation of caspase-8 and then caspase-3 and caspase-7, which are commonly known to have 'executioner' roles in apoptosis, promotes pro-inflammatory activation of microglia in the absence of cell death 7 . We sought to determine whether glioma-induced microglia activation involves caspase-dependent signaling pathways. We found that S-nitrosylation of microglial caspase-3 induced by glioma cells contributed to the polarization of microglia into a tumor-supportive phenotype that was necessary for glioma expansion.
RESULTS

Glioma cells decrease basal caspase-3 activity in microglia
Using a segregated coculture transwell set-up ( Supplementary Fig. 1a) , we assessed the cleavage of a proluminescent substrate containing the tetrapeptide sequence DEVD (DEVDase activity), which reflects caspase-3-like enzymatic activity, in mouse BV2 microglia cells stimulated by soluble factors originating from glioma cells of various origins. Basal DEVDase activity was reduced in the BV2 microglia cells following segregated coculture with rat C6 glioma cells (Fig. 1a) , an effect that was also observed in joined coculture conditions (Fig. 1b) . Decreased microglial caspase-3-like enzymatic activity following exposure to glioma-derived soluble factors was further confirmed with additional segregated coculture combinations with the human CHME3 microglia cell line (Fig. 1c) and mouse or human primary microglia (Fig. 1d) , and a panel of glioma cell lines of various origins (human U-251MG, U-343MG, U-373MG, U-1241MG and U-87MG cells and mouse GL261 cells) (Fig. 1a-d) . In contrast, caspase-8 enzymatic activity, as measured by the cleavage of a proluminescent substrate containing the tetrapeptide sequence LETD (LETDase activity), was found to be mostly unaffected in BV2 microglia cells in segregated coculture with glioma cells (Supplementary Fig. 1b) , which suggested that the suppression of caspase-3-like activity was independent of caspase-8 activity. Notably, it has been reported that the pro-inflammatory activation of microglia relies on successive activation of caspase-8 and caspase-3 (ref. 7) , which indicates that polarization of microglia cells toward a tumor-supporting phenotype depends on a distinct signaling pathway. In confirmation of the soluble nature of the stimulus released by the glioma cells, conditioned medium from C6 cells reduced DEVDase activity in both BV2 microglia and primary microglia isolated from mouse cortex (Fig. 1e) . The decrease in microglial basal caspase-3-like activity that we observed in microglia-glioma segregated coculture correlated with a reduction in the expression of the active p19 subunit of caspase-3 ( Fig. 1f) and a corresponding increase in the expression of its inactive zymogene, procaspase- 3 (refs. 8,9) (Fig. 1g) .
To determine the physiological relevance of the findings reported above, we performed in vivo experiments and injected green fluorescent protein (GFP)-expressing GL261 glioblastoma cells (GFP-GL261 cells) into the brains of postnatal day 16-17 C57/BL6/J mice 10, 11 ( Supplementary Fig. 1c ). This syngeneic-transplant-tumor model in immunocompetent mice has been shown, at the time points used, to exhibit limited infiltration by peripheral monocytes or macrophages 12 . Immunohistochemical analysis of brain tissue surrounding the grown gliomas at 1 week and 2 weeks after transplantation revealed a massive recruitment of microglia cells expressing the microglia marker Iba1, and the abundance of cleaved caspase-3 in microglia cells was substantially lower in cells located inside the tumor mass than in cells residing at the periphery of the tumor (Fig. 1h-j) . We confirmed that decrease in the microglial abundance of cleaved caspase-3 inside the tumor in another transplant-tumor model in which we injected human U-87MG glioblastoma cells into the brains of mice of the non-obese diabetic-severe combined immunodeficiency strain and analyzed the response of microglia. Immunohistochemical analysis of brain tissue, including the glioma tumors that formed 1 week after transplantation, Fig. 2a,b) . In conclusion, the data obtained from human-and murine-originating microglia and glioma cells, and the results of our in vivo experiments in two different transplant-tumor models, supported the idea that the gliomas inhibited microglial basal caspase-3 activity.
Knockdown of caspase-3 promotes a tumor-supportive phenotype We hypothesized that the observed downregulation of microglial caspase-3 activity in response to a glioma stimulus would contribute to polarization of the microglia cells toward their tumor-promoting functions. Thus, we assessed the role of caspase-3 in the activation of BV2 microglia by knocking down endogenous procaspase-3 using a pool of small interfering RNAs (siRNAs) (Fig. 2a) , which mimicked the effect of glioma cells on basal microglial DEVDase activity (Fig. 2b) . BV2 monocultures, and BV2 cells in segregated coculture with C6 glioma cells, were used for comparisons. Microglia activation was assessed using a profiling PCR array that encompasses 84 key genes encoding products that are central to the wound-healing response. Many of these signaling pathways and associated functions are shared with the pro-tumorigenic phenotype of myeloid cells, as they can promote cell proliferation, tissue remodeling, angiogenesis and the development of an immunosuppressive environment 13 . The gene-expression array revealed that silencing of the gene encoding caspase-3 itself in microglia was able to trigger a tumorsupportive-like phenotype and to act in synergy with the stimulating effects of glioma cells (Fig. 2c) . The most notable gene expression increase was observed for the gene encoding interleukin 6 (IL-6), is relevant in a clinical context, as elevated IL-6 expression is associated with poor survival of patients with glioma 14 . IL-6 signaling seems to contribute to glioma malignancy through the promotion of glioma stem-cell growth and survival 14 . In addition, IL-6 participates in the maintenance of the microglial tumor-supportive functions 15 . Induction of Il6 mRNA expression and that of mRNA encoding three additional markers associated with the microglial tumor-supportive phenotype (not included in the above array)-the chemokine Ccl22, the chitinase-like molecule Chil3 (also known as Ym1) and the matrix metalloproteinase Mmp14 (ref. 4)-was further confirmed by quantitative PCR (qPCR) analysis following segregated coculture of BV2 cells with C6 or GL261 glioma cells ( Fig. 2d and Supplementary  Fig. 3 ). Microglial expression of Nos2, which encodes the nitric-oxide synthase NOS2 (also known as 'inducible NOS') and whose induction is strongly associated with the pro-inflammatory phenotype of these BV2 cells, was substantially decreased following knockdown of caspase-3 and was abrogated even after segregated coculture with C6 or GL261 glioma cells ( Fig. 2d and Supplementary Fig. 3 ).
Using Transwell cell-migration and cell-invasion assays, we investigated whether the inhibition of caspase-3 by selective knockdown in microglia was associated with increased glioma motility and invasiveness. Microglia cause an increase in glioma mobility and invasiveness 1, 2 . We observed that reducing microglial caspase-3 expression further increased the migratory and invasive functions of glioma cells (Fig. 2e) .
Microglia cells are recruited in an activated state before being converted into tumor-supporting cells by the glioma cells 16, 17 . Thus, to assess the strength of the glioma-mediated repression of microglial caspase-3 and its effect on the polarization of the microglia toward a pro-tumor phenotype, we pre-treated BV2 cells for 24 h with lipopolysaccharide (LPS) before challenging them for an additional 6 h in a glioma coculture set-up ( Fig. 3a-d) . It has been reported that treatment with LPS induces DEVDase activity in microglia and that this activity is linked to microglial pro-inflammatory activation 7 . Glioma cells diminished the LPS-induced expression of the active caspase-3 subunit and the associated enzymatic activity (Fig. 3a,c) . In contrast, we found that LPS-induced microglial caspase-8 activity (as assessed by LETDase) was unaffected by the presence of glioma cells (Fig. 3b) . In accordance with those findings, glioma cells efficiently reduced the LPS-induced expression of NOS2 in microglia (Fig. 3d) . Collectively, these data indicated that inhibition of caspase-3 contributed to the microglial tumor-supportive activation state.
Glioma NOS2 contributes to S-nitrosylation of caspase-3 Our next step was to elucidate how inhibition of caspase-3 is achieved in microglia cells. The possibility of repression of caspase-3 activity via potential downregulation of the basal enzymatic activity of its upstream regulator caspase-8 could already be excluded, as LETDase activity was not found to be substantially affected during gliomainduced microglia activation (Supplementary Fig. 1b) . The expression of mRNA encoding these two caspases could not explain the observed reduction in caspase-3 activity in microglia following coculture with glioma cells (Supplementary Fig. 4a,b) .
Published studies support the proposal of a tumor-promoting role for endogenous nitric oxide (NO) in malignant glioma 18, 19 . Of particular interest to us, NO produced by NOS has long been recognized as being instrumental in the regulation of caspase-3 activation 20, 21 . Indeed, caspase-3 zymogen is subject to reversible inhibitory S-nitrosylation at its catalytic Cys163 active site, which regulates its enzymatic activity (S-nitrosylated procaspase-3 is called 'SNO-procaspase-3' here) 22, 23 . In agreement with the likely involvement of NOS-produced NO in the glioma-induced repression of microglial caspase-3 activity, treatment with L-NAME (a pan-inhibitor of NOS) or with carboxy-PTIO (a NO scavenger) effectively prevented the decrease in DEVDase activity observed in BV2 cells and primary mouse microglia following coculture with glioma cells (Fig. 4a) . Furthermore, using the biotin-switch method 24 , we quantified the extent of S-nitrosylation of microglial procaspase-3 in segregated microglia-glioma cocultures compared with that in microglia monoculture conditions. Indeed, a greater abundance of SNO-procaspase-3 was observed in microglia cells following coculture with glioma cells (Fig. 4b) . Using an in situ proximity ligation assay to identify proteins with SNO-Cys residues 25 , we found increased S-nitrosocysteine post-translational modification of procaspase-3 in microglia under segregated coculture conditions (Fig. 4c) .
Finally, we sought to identify the source of NO used for S-nitrosylation of caspase-3. NOS2 produces NO in response to various stimuli. Use of the selective NOS2 inhibitor 1400W abrogated glioma-induced repression of microglial DEVDase activity (Fig. 4a) . In this gliomamicroglia cell communication system, two potential cell origins for NO production can be envisaged. However, almost complete abrogation of Nos2 mRNA expression was observed in BV2 microglia following 6 h of coculture with C6 glioma cells (Fig. 2d) , which suggested that the NO should have originated from the C6 glioma cells. In contrast to the effect of glioma on microglia NOS2 expression, we found that microglia cells promoted Nos2 mRNA expression in glioma cells following coculture (Fig. 4d) . We found that pooled siRNA targeting Nos2 negatively affected the ability of C6 glioma cells to repress microglial caspase-3-like activity (Fig. 4e,f) . Thus, NOS2 activity originating from the glioma cells seemed to act as an initiating stimulus in the control of microglial caspase-3 activity.
Trx2 activity prevents S-nitrosylation of caspase-3
The thioredoxin (Trx) family of small redox proteins has been reported to affect the nitrosylation status of caspase-3 (refs. 22, 23, 26) . Mammals have two classical Trx proteins, cytosolic or nuclear thioredoxin-1 (Trx1) and mitochondrial thioredoxin-2 (Trx2), both of which have been identified as major protein denitrosylases. Under certain conditions, Trx1 can also catalyze the trans-S-nitrosylation of proteins through mechanisms involving its Cys69 or Cys73 residues, which are not present in Trx2 (ref. 26) . We therefore decided to assess the respective roles of the Trx proteins in regulating the nitrosylation status of caspase-3 and thus its proteolytic activity, by selectively knocking down endogenous Txn1 or Txn2 (hereafter referred as Trx1 or Trx2) in BV2 microglia cells ( Supplementary  Fig. 5a ). BV2 microglia cells transfected with a siRNA pool specifically targeting Trx1 exhibited greater caspase-3-like activity than those of cells transfected with non-targeting control siRNA monoculture, but cells transfected with a siRNA pool specifically targeting Trx2 did not (Fig. 5a) . However, when BV2 microglia cells were transfected with siRNA specifically targeting Trx2, glioma cells did not repress caspase-3-like activity in microglia, proportionally, as effectively as the repression found in their respective monocultures (Fig. 5a) . Fig. 5b ). In addition, following coculture with glioma cells, we observed increased S-nitrosylation of Trx2 (Supplementary Fig. 5c ) but decreased mitochondrial Trx activity (Supplementary Fig. 5d ) in microglia cells, which would account for the activity of the mitochondria-specific Trx2. Overall, the glioma's influence over microglia cells appeared to be associated with inhibition of the Trx redox system (with reduction of both thioredoxin activity and thioredoxin reductase activity; Supplementary  Fig. 5d,e) . Notably, we found that reducing microglial Trx2 expression recapitulated the effect of glioma cells stimulation on the abundance of SNO-procaspase-3 in microglia (Fig. 5b) , which suggested that regulation of Trx2 accounted for the phenomenon observed. Given that Trx2 is a mitochondria-specific thioredoxin and that procaspase-3 can be found in both the cytosolic compartment and mitochondrial compartment of the cell, we sought to determine the subcellular compartment(s) in which glioma-induced induction of microglial SNO-procaspase-3 occurs. Subcellular fractionation experiments revealed that procaspase-3 was present in both the cytosolic fraction and mitochondrial fraction of microglia cells, whereas cleaved caspase-3 was detected only in the cytosolic fraction (Fig. 5c) , which also accounted for most of the DEVDase activity in the cell (Fig. 5d) . In addition, following coculture with glioma cells, decreased levels of cleaved caspase-3 and associated caspase-3-like activity was observed in the cytosol of microglia cells (Fig. 5c,d) . Finally, we also found that increased S-nitrosylation of procaspase-3 occurred mainly in the mitochondria of microglia cells following stimulation by glioma cells (Fig. 5e) . Thus, these results indicated that inhibition of Trx2-mediated denitrosylation of mitochondrial SNO-procaspase-3 was part of the microglial activation pathway initiated by glioma cancer cells.
Glioma NOS2 inhibits microglial caspase-3 activity
Collectively, the data reported above suggested a microglia-glioma cell-cell communication signaling pathway in which NO produced by NOS2 in glioma cells led to S-nitrosylation-dependent inhibition of Trx2 activity in microglia, which in turn resulted in increased S-nitrosylation and inhibition of caspase-3, an event that promoted the tumor-supportive phenotype of microglia. To confirm the existence of this signaling pathway in vivo, we inhibited the most upstream component, NOS2, in glioma cells, and assessed its biological effects on tumor growth and microglia recruitment in vivo. We used viral delivery of short hairpin RNA (shRNA) targeting Nos2 (Nos2-shRNA) to establish GL261 derivatives with stable knockdown of Nos2 (Fig. 6a) . GL261 glioma cells expressing Nos2-shRNA were less able to reduce microglial caspase-3-like activity than were cells expressing non-targeting npg control shRNA (Fig. 6b) . We injected GFP-GL261 cells expressing control shRNA or a Nos2-shRNA into postnatal day 16-17 C57/ BL6/J mice brains 12 . Immunohistochemical analysis of brain tissues at 1 and 2 weeks after that transplantation revealed markedly less tumor growth in mice given injection of Nos2-shRNA-expressing GFP-GL261 cells than in those given injection of control-shRNAexpressing GFP-GL261 cells (Fig. 6c-f) . The accumulation of Iba1 + amoeboid (activated) microglia in and around the implanted glioma was much lower in mice given injection of Nos2-shRNA-expressing GFP-GL261 cells than in those given injection of control-shRNAexpressing GFP-GL261 cells (Fig. 6c-f) . These in vivo experiments suggested that NOS2 activity in glioma contributed to the recruitment of microglia toward the tumor.
Microglial depletion of caspase-3 supports glioma tumor growth Microglia are characterized by prominent expression of the chemokine receptor CX3CR1. Given the cellular kinetics of blood-cell replenishment versus microglial longevity, mice with tamoxifeninducible expression of Cre recombinase fused to the ligand-binding domain of the estrogen receptor variant ERT2 under the control of Cx3cr1 promoter-enhancer elements (Cx3cr1 CreERT2 mice) allows the generation (in response to tamoxifen treatment) of mice with specific genetic manipulations restricted to microglia 27, 28 . To provide direct evidence that only microglia-related caspase-3 is important for glioma expansion in vivo, we crossed mice bearing Casp3 alleles flanked with loxP at exon 2 (Casp3 flox/flox mice) 29 with Cx3cr1 CreERT2 mice (Fig. 7a) . Casp3 deletion was first evaluated 5 d after the last tamoxifen treatment, which induced deletion of Casp3 specifically in microglia cells (Fig. 7a) . Microglia were isolated by immunomagnetic cell sorting, and qPCR analysis demonstrated higher efficiency of microglial Casp3 deletion (>75%) in Casp3 flox/flox Cx3cr1 CreERT2 mouse brains (with caspase-3-deficient microglia) than in Casp3 flox/flox mouse brains (used as a control) (data not shown). It could be argued that microglia lacking caspase-3 could be replaced by newly generated microglial cells expressing this critical caspase. However, identical analysis performed at 6 months after tamoxifen treatment revealed sustained deletion of Casp3 in microglia cell population ( Supplementary Fig. 6a ), consistent with the reported long-lived nature and limited self-renewal of microglia 30 . Analysis of striatum and cortex brain regions did not reveal any greater abundance of the microglia cell populations in Casp3 flox/flox Cx3cr1 CreERT2 mouse brains than in Casp3 flox/flox mouse brains ( Supplementary  Fig. 6b-d) . When GFP-GL261 cells were injected into the brains of postnatal day 16-18 Casp3 flox/flox and Casp3 flox/flox Cx3cr1 CreERT2 mice, immunohistochemical analysis of brain tissues at 1 and 2 weeks after transplantation revealed a greater increase in the tumor size following conditional depletion of caspase-3 in microglia than in the control condition (Fig. 7b-e) . In summary, specific ablation of microglial caspase-3 positively affected the tumor-supportive function of these cells and thus glioma expansion in vivo. Collectively, these data indicate that glioma-induced microglia conversion is coupled to a reduction in basal microglial caspase-3 activity and increased S-nitrosylation of mitochondria-associated caspase-3 through inhibition of thioredoxin-2 activity, and that caspase-3 inhibition regulates microglial tumor-supporting function (Supplementary Fig. 7a,b) .
DISCUSSION
Malignant gliomas are highly aggressive primary brain tumors with limited therapeutic options and a dismal prognosis for patients 31 . Gliomas are heterogeneous in their composition of true tumors cells and their range of intermingling non-neoplastic cells, which also have vital roles in controlling the course of the pathology. In fact, the pathological incident of a brain tumor induces the accumulation of myeloid cells, especially at the tumor edge, which can constitute up to one third of the glioma tumor mass 32 . These are composed of microglia, the resident immune cells of the central nervous system (CNS), and macrophages derived from outside the CNS. The respective effects of brain-resident microglia versus macrophages originating from extra-CNS sources on tumor progression has been the subject of intense debate 2 . However, studies of head-protected irradiation chimeras have shown in glioma mouse models that resident microglia represent the main and early source of myeloid cells in glioma. Peripheral macrophages are only found to infiltrate at the late stage of tumor growth and represent ~25% of all myeloid cells 12, 33 . Selective depletion of microglia from ex vivo cultured organotypic brain slices or murine in vivo models further illustrates the essential role of microglia cells themselves in controlling glioma growth 
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A r t i c l e s and invasion or even tumor angiogenesis 3, 4, 33, 34 . There is growing recognition of the functions of microglia in glioma maintenance and progression 2 . During the course of disease, microglia undergo functional changes toward a tumor-supportive phenotype. However, the underlying molecular mechanism used by glioma cells to transform the microglial cell population remains elusive. Published studies support the proposal of a tumor-promoting role for endogenous NO and NO synthases in malignant glioma 18, 19, 35 . Evaluation of data contained in the REMBRANDT ('repository of molecular brain neoplasia data') database reveals that high NOS2 expression correlates with decreased survival of patients with glioma. Furthermore, it has been shown in a mouse glioma model that inhibition of NOS2, particularly in the glioma stem-cell population, can slow glioma growth 19 . We have provided evidence that gliomaderived NO was critical for the control of microglia activation and have thereby exposed a previously unknown role for NOS2 in glioma. In vivo, repressing glioma NOS2 expression resulted in reduced accumulation of microglia in and around implanted glioma, which correlated with decreased tumor expansion. We found that NOS2 contributed to the repression of caspase-3 function in the microglia via S-nitrosylation of the protease. Our results have also provided evidence that inhibition of Trx2-mediated denitrosylation activity accounted for the observed increase in SNO-procaspase-3.
Even if so-called 'killer caspases' , such as caspase-3, are seen as the 'usual suspects' in the death of cells, the idea that the apoptotic caspases are more than just killers is supported by numerous studies.
In the brain, activation of caspase-3 can occur in various cell types as a part of multiple non-apoptotic, essential cell functions [36] [37] [38] . For microglia, it has been reported that controlled activation of caspase-3 contributes to the activation of these cells toward the pro-inflammatory phenotype in the absence of death 7, 9, 39 . We found that gliomainduced microglia conversion was coupled to a reduction in basal microglial caspase-3 activity, and that caspase-3 inhibition regulated microglial tumor-supporting function. Finally, to provide direct evidence that only microglia-related caspase-3 is important for glioma expansion in vivo, we used Casp3 flox/flox Cx3cr1 CreERT2 mice, which allows the generation (in response to tamoxifen treatment) of mice with specific genetic manipulations restricted to microglia 27, 28 . After injection of glioma cells, Casp3 flox/flox Cx3cr1 CreERT2 mice had a greater increase in tumor size compared with that of Casp3 flox/flox mice brains at 1 and 2 weeks after transplantation.
In summary, we have identified a previously unknown role for caspase-3 in the control of microglia activation in the context of glioma expansion. We found that inhibition of basal caspase-3 activity in microglia was associated with the polarization of these cells toward a tumor-supportive phenotype. Despite the importance of microglia in the maintenance of CNS homeostasis and the pathogenesis of neurodegenerative diseases and brain tumors, the molecular mechanisms behind their polarization toward selective phenotypes has remained unclear. Our investigations have identified a pivotal role for caspase-3 in the regulation of microglia biology. Caspase-3 might work as a 'rheostat' that controls microglial-cell fate in response to diverse stimuli, whereby npg elevated activity of the protease leads to cell death but low activity and reduced basal caspase-3 activity regulate the pro-inflammatory and the tumor-supporting microglial activation states, respectively. Thus, caspase-3 might serve as a key determinant for microglial polarization, and its modulation could have therapeutic benefits in combatting brain diseases in which microglia are involved in pathogenesis.
METhODS
Methods and any associated references are available in the online version of the paper.
Accession codes. GEO: microarray data, GSE84772. buffer A and incubated for 1 h in a humidity chamber at 37 °C with PLA probes detecting mouse or rabbit antibodies (Duolink II PLA probe anti-rabbit plus and Duolink II PLA probe anti-mouse minus diluted in the antibody diluent to a concentration of 1:5). After washing with buffer A, cells were incubated for 30 min at 37 °C with the ligation solution (Duolink II Ligation stock 1:5 and Duolink II Ligase 1:40). If the two protein targets are in close proximity, a template is formed for amplification. Detection of the amplified probe was done with the Duolink II Detection Reagents Red Kit. After repeated washing at room temperature 20-25 °C with wash buffer B, coverslips were mounted onto slides using mounting medium containing DAPI and samples were observed using a confocal microscope. Protein-protein interaction was measured as the number of fluorescent dots/cell analyzed with Duolink Image tool. As negative control, cells were treated with 0.2% HgCl 2 for 30 min at room temperature 20-25 °C before PLA 44 .
Measurement of Trx and TrxR activities in cell lysates.
To quantify the activities of Trx and TrxR in cell lysates, we used an end point assay kit (IMCO Ltd AB) based on the reduction of insulin disulfides by reduced Trx with TrxR and NADPH as ultimate electron donor.
RNA isolation cDNA synthesis and qPCR. RNA was isolated from 2 × 10 5 cells using the total RNA extraction kit (Qiagen). cDNA was synthesized from 1 µg RNA using Oligo dT, dNTPs, and Superscript II (Invitrogen). qPCR was performed using Sybr ® Green reagents (Applied Biosystems) and primers listed in Supplementary Table 4 . Results were calculated using delta Ct method and represented as a fold over control cells.
Gene expression array analysis. The mouse wound healing RT 2 profiler PCR array (PAMM-121Z; Qiagen) was used to profile the expression of 84 genes central to the wound healing response using manufacturer's instructions. cDNAs were synthesized from 1 µg of mRNA using RT 2 First Strand Kit from Qiagen.
Transwell migration and invasion assays. 8 µm-pore width transparent PET membrane inserts (Transwell, Corning) were used to measure cell migration capability. To quantify the cell invasion capability, the inserts were coated with 300 µg/ml Growth Factor Reduced Matrigel Matrix (Corning). 100 µl of Matrigel Matrix was added per insert and air-dried under sterile conditions at 37 °C. C6 glioma cells were seeded on top of the insert and BV2 microglia were seeded in the lower compartment. Once the experiment was finalized, the membranes from the inserts were washed with PBS and carefully cut out with a blade. Later on, the membranes were mounted with ProLong Gold antifade reagent with DAPI (Life technologies) and the nuclei of the migrated cells were counted under fluorescent microscopy.
